NCT02825537

Brief Summary

The main objective of this study is to compare precisely, under standardized test conditions, water balance changes in healthy subjects with or without the daytime use of compression stocking.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2016

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 30, 2016

Completed
1 day until next milestone

Study Start

First participant enrolled

July 1, 2016

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 7, 2016

Completed
25 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2016

Completed
Last Updated

August 24, 2016

Status Verified

August 1, 2016

Enrollment Period

1 month

First QC Date

June 30, 2016

Last Update Submit

August 23, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Evolution of the total bodily fluid volume in the daytime sequence measured by impedancemetry with or without daytime use of compression stocking

    adjusted over 3 consecutive days

Secondary Outcomes (8)

  • Evolution of the water balance in daytime sequence,in night sequence and on a 24h sequence with or without daytime use of compression stocking

    adjusted over 3 consecutive days

  • Evolution of the subject's weight (in kilograms), in daytime sequence, in night sequence and on a 24 h sequence with or without daytime use of compression stocking

    adjusted over 3 consecutive days

  • Evolution of the volume of urine determined by weight (in kilograms),in daytime sequence, in night sequence and a 24h sequence with or without daytime use of compression stocking

    adjusted over 3 consecutive days

  • Evolution days of the neck circumference (in centimeter) in a dynamic sequence, in supine sequence and on a 24h sequence with or without daytime use of compression stocking

    adjusted over 3 consecutive days

  • Evolution of leg perimeters (in centimeter) in 3 points in dynamic sequence, in supine sequence , and over 24h sequence with or without daytime use of compression stocking

    adjusted over 3 consecutive days

  • +3 more secondary outcomes

Study Arms (2)

With use of compression stocking

EXPERIMENTAL

Use of compression stocking during 3 consecutives days

Device: Compression stocking

Without use of compression stocking

OTHER

No use of compression stocking during 3 consecutives days

Other: No use of compression stocking

Interventions

A class III (20 to 36 mm Hg) elastic compression stocking according to the french classification

With use of compression stocking

No use of compression stocking

Without use of compression stocking

Eligibility Criteria

Age40 Years+
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male subject aged 40 years old or more,
  • Subject with a Body Mass Index (BMI) between 18.5 and 30 kg/m²,
  • Subject with a body fat percentage between 11 and 27 % of his weight, as measured by impedancemetry,
  • Subject with a muscle mass index of less than 55% of his weight, as measured by impedancemetry,
  • Subject with a water status, as measured by impedancemetry, between + / - 5 liters of his normal value, as indicated by the impedancemetry,
  • Healthy subject, registered in the French biomedical research volunteer national database,
  • Subject whose lower limb measurements correspond to the size grid of the compression stocking used,
  • Subject agreeing to abstain from alcohol intake during all hospitalization periods,
  • Subject practicing under 5 hours of intense physical activity per week, on average, in the 4 weeks preceding the screening visit (marathon training, military training ...),
  • Subject agreeing to abstain from any strenuous activity , especially sports, from the screening visit to the end of study (including during the out-patient period),
  • Subject accepting the constraints of the study,
  • Subject being available during the whole period of the study,
  • Subject who has signed the consent form after being adequately informed and receiving the information sheet,
  • Subject affiliated to the French social security system or receiving benefits of that type.

You may not qualify if:

  • Subject who is a smoker or a former smoker who stopped smoking less than 6 months ago,
  • Subject following a salt-free diet,
  • Subject following or planning to follow a diet,
  • Subject having a temperature ≥ 38,5°C in the morning,
  • Subject having, upon clinical examination, a systolic blood pressure (SBP) \< 91 mmHg or \> 139 mmHg, a diastolic blood pressure (DBP) \< 41 mmHg or \> 89 mmHg, or a heart rate (HR) \< 40 bpm or \> 100 bpm, and judged clinically significant by the investigator,
  • Subject having an intestinal transit disorder that disrupts hydroelectric balance,
  • Alcohol-dependent subject or subject with a positive alcohol breath test,
  • Subject suffering from insulin-dependent or uncontrolled diabetes (controlled diabetes is accepted),
  • Subject with a serious, stabilized, or progressive illness (as judged by the investigator),
  • Subject with hypertension or heart failure,
  • Subject with known renal function disorders,
  • Subject with known liver failure,
  • Subject with venous insufficiency of clinical class C3, C4, C5 or C6 according to the Clinical / Etiological / Anatomical / Pathophysiological (CEAP) classification,
  • Subject following long-term therapy with diuretics, nonsteroidal anti-inflammatory drugs (NSAIDs), steroids, nutritional supplements or opiates,
  • Subject having, upon questioning or clinical examination, advanced peripheral neuropathy, skin infections, eczematous dermatitis, or weeping skin disorder of the leg,
  • +6 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Biotrial

Rennes, 35042, France

Location

MeSH Terms

Interventions

Stockings, Compression

Intervention Hierarchy (Ancestors)

Compression BandagesBandagesEquipment and Supplies

Study Officials

  • Hakim Charfi, MD

    Biotrial

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 30, 2016

First Posted

July 7, 2016

Study Start

July 1, 2016

Primary Completion

August 1, 2016

Study Completion

August 1, 2016

Last Updated

August 24, 2016

Record last verified: 2016-08

Locations